Edward J Dulac Iii Intellia Therapeutics, Inc. (NTLA) insider trading activity

Edward J Dulac Iii is EVP, Chief Financial Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 99,683 shares of NTLA, which is worth approximately $867,242. The most recent transaction as insider was on Jan 05, 2026, when has been sold 6,379 shares (Common Stock) at a price of $9.21 per share, resulting in proceeds of $58,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.7K

6.01% 3M change

50.3% 12M change

Total Value Held $867,242

Edward J Dulac III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2026	SELL Open market or private sale	$58,750 $9.21 p/Share	6,379 Reduced 6.01%	99,683 Common Stock
Jul 23 2025	SELL Open market or private sale	$104,617 $14.02 p/Share	7,462 Reduced 6.57%	106,062 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	47,200 Added 29.37%	113,524 Common Stock
Jul 22 2024	BUY Grant, award, or other acquisition	-	66,324 Added 50.0%	66,324 Common Stock

Also insider at

FATE

FATE THERAPEUTICS INC Healthcare

Chief Financial Officer

EJD